Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
Kayla Garrett/LinkedIn and Vittorio Pengo/youtube.com
Jun 4, 2026, 16:14

Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing

Kayla Garrett, Senior Talent Acquisition Partner at Roche, shared a post on LinkedIn:

“When a patient is diagnosed with Lupus, looking deeper is critical. Confirming or excluding the severe complication known as Antiphospholipid Syndrome (APS) relies heavily on accurate Lupus Anticoagulant (LA) testing.

However, LA testing is a uniquely demanding analytical challenge, and an incorrect result can significantly impact patient management.

In our latest interview, global thrombosis authority Prof. Vittorio Pengo zooms in on the rigorous diagnostic requirements needed to get LA testing right.

He explains:

  • The mandatory 3-step procedure: Why screening, mixing, and confirmatory steps provide non-redundant information and cannot be safely abbreviated.
  • The necessity of parallel testing: Why relying on a single test is misleading, and why both dRVVT and aPTT-based assays are required.
  • The limits of automation: Why dedicated human expertise is essential to interpret complex, paradoxical findings—such as the ‘Lupus cofactor’ effect—that automation simply cannot resolve.

Ready to take a closer look at your lab’s coagulation diagnostics?

Read our full deep dive with Prof. Pengo to ensure accurate APS detection.”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.

Antiphospholipid Syndrome APS aPTT bleeding disorders Blood dRVVT Health Hematology Hemostasis News Hemostasis Today Kayla Garrett LA Lupus Lupus Anticoagulant Medicine Vittorio Pengo
NewsFeed